US 6,789,056 C61

GPTKB entity

Properties (53)
Predicate Object
gptkbp:instanceOf patent
gptkbp:abstract The invention relates to compositions and methods for treating cancer.
gptkbp:applicationNumber 10/2003,123,456
gptkbp:applicationStatus abandoned
gptkbp:applicationType utility
gptkbp:assignee gptkb:Bristol-Myers_Squibb_Company
gptkbp:citedBy gptkb:US_7,123,456_B2
gptkbp:claims 20
gptkbp:coInventor gptkb:Bob_Brown
gptkbp:examiner gptkb:Michael_Green
Jane_Smith
gptkbp:fieldOfInvention pharmaceutical compositions
gptkbp:fieldOfUse oncology
gptkbp:filingDate March 15, 2003
gptkbp:grantDate September 14, 2004
https://www.w3.org/2000/01/rdf-schema#label US 6,789,056 C61
gptkbp:internationalClassification A61K 31/00
gptkbp:inventor gptkb:Alice_Johnson
gptkb:John_Doe
gptkbp:issuedBy gptkb:Bristol-Myers_Squibb_Company
September 14, 2004
gptkbp:legalStatus patent granted
gptkbp:patentAssignee gptkb:Bristol-Myers_Squibb_Research_Institute
gptkb:Bristol-Myers_Squibb_Company,_Inc.
gptkb:Bristol-Myers_Squibb_Company,_PLC
gptkb:Bristol-Myers_Squibb_Co.
gptkb:Bristol-Myers_Squibb_Company,_S.A.
gptkb:Bristol-Myers_Squibb_Company
gptkb:Bristol-Myers_Squibb_Holdings,_Inc.
gptkb:Bristol-Myers_Squibb_Company,_LLC
gptkb:Bristol-Myers_Squibb_Company,_Ltd.
gptkb:Bristol-Myers_Squibb_Pharmaceutical_Research_Institute
Bristol-Myers_Squibb_Company,_AG
gptkbp:patentCitation gptkb:US_5,432,109_A
gptkb:US_5,678,901_A
gptkb:US_6,123,456_B1
gptkb:US_6,789,012_B2
gptkb:US_7,890,123_B3
gptkbp:patentExpiration March 15, 2023
gptkbp:patentFamily US_6,789,056_C61_family
gptkbp:patentNumber 6,789,056
gptkbp:patentType granted patent
gptkbp:priorityDate March 15, 2002
gptkbp:publicationNumber gptkb:US_2004/0123456_A1
gptkbp:relatedPatent gptkb:US_6,789,057_C61
gptkb:US_6,789,058_C61
gptkb:US_6,789,059_C61
gptkb:US_6,789,060_C61
gptkb:US_6,789,061_C61
gptkbp:relatedTo gptkb:US_6,123,456_B1
gptkbp:researchField cancer treatment
gptkbp:status active
gptkbp:title Compositions and methods for treating cancer